Tuesday Last.

According to the House subcommittee hearing, such offers produced between 1993 and 2008 have price US consumers at least $12 billion yearly. Democrats in Congress possess recently introduced legislation in both House and the Senate that could make such deals illegal. However, if profits from medication patents are curtailed, businesses might have less cash to invest in riskier research that could lead to the advancement of new types of medicines. This, in turn, could reduce the true number of drugs available to consumers. What do you think can be achieved to provide consumers with affordable drugs and keep cash flowing to R&D at the same time? Photo by klynslis..The annual award, the highest honor bestowed by ACS, consists of a gold medallion made to commemorate the work of Joseph Priestley as well as a presentation package and a certificate. ‘This function is changing not only what we know, but how we think about the interplay of structure also, function and dynamics in molecular systems,’ said David A. Tirrell, Ph.D., a Caltech professor and former chair of the Division of Chemical substance and Chemistry Engineering. Tirrell provides that the advances made by Zewail’s group ‘are yielding qualitatively new insights in to the atomic and molecular origins of complex chemical substance, physical, and biological behavior.’ Zewail pioneered femtochemistry, the analysis of ultrafast chemical processes on the femtosecond timescale using special lasers.